Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Price weighting biases index behavior differently than market-cap methods. This overview explains the mechanics and the practical impact on portfolio results.
25,428 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
As the 10-year Treasury crosses 4.6%, ETF dynamics for VOO and IVV face renewed scrutiny. Markets weigh rate paths, i...
SpaceX joining the Nasdaq-100 would be a major headline, but the real questions are about risk, weighting, and portfo...
What happens when AI breakthroughs and high-flying tech bets collide with political markets? This article explains th...
Markets rewarded the Trump policy playbook for years, but a shift in Federal Reserve policy could slow the rally. Thi...
Recession fears are resurging, but your best move isn’t to panic. This guide explains why time in the market beats ti...
A small group of mega-cap stocks can tilt the entire market. This in-depth look explains how the magnificent seven sh...
Today’s market moves show a tech-led rally fueled by Rocket Lab’s big acquisition. This article breaks down what happ...
The FTSE Russell semi-annual rebalancing will drive heavy trading as index funds realign weights. Markets brace for v...
SpaceX’s rapid move into index funds signals a shift in how private tech breakthroughs reach everyday investors. This...
PrimeXBT launches PXTrader 2.0, a major upgrade that merges crypto and traditional markets on a single platform. Trad...
The VIX surges about 10% as Brent breaches the $100 mark, signaling rising fear among traders and a shift toward risk...